Guillain-Barré Syndrome Following Hepatitis B Vaccination

Overview

Journal Clin Exp Rheumatol

Specialty Rheumatology

Date 2005 Jan 11

PMID 15638054

Citations 14

Authors

M Khamaisi

Y Shoenfeld

H Orbach

Affiliations

Soon will be listed here.

Abstract

A 52-year-old woman developed Guillain-Barré syndrome 10 weeks after immunization with recombinant hepatitis B vaccine. Common infectious causes of GBS were ruled out. The temporal relationship between GBS and hepatitis B virus (HBV) vaccination was suggestive of a vaccine-induced cause. The possible mechanisms of this very, rare complication are discussed.

Citing Articles

Clinical study of the relationship between hepatitis B core antibody and mechanical ventilation in patients with Guillain-Barré syndrome.

Zhang W, Yao Q, Wang Y, Yin J, Yang X Front Neurol. 2025; 16:1530286.

PMID: 40066308 PMC: 11891066. DOI: 10.3389/fneur.2025.1530286.

Pharmacovigilance in Vaccines: Importance, Main Aspects, Perspectives, and Challenges-A Narrative Review.

Hodel K, Sampaio Dotto Fiuza B, Conceicao R, Aleluia A, Pitanga T, Moraes Dos Santos Fonseca L Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931474 PMC: 11206969. DOI: 10.3390/ph17060807.

Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis B Virus Infections.

Songtanin B, Chaisrimaneepan N, Mendoza R, Nugent K Viruses. 2024; 16(4).

PMID: 38675959 PMC: 11055091. DOI: 10.3390/v16040618.

COVID-19 as a trigger of Guillain-Barré syndrome: A review of the molecular mechanism.

Malekpour M, Khanmohammadi S, Meybodi M, Shekouh D, Rahmanian M, Kardeh S Immun Inflamm Dis. 2023; 11(5):e875.

PMID: 37249286 PMC: 10187022. DOI: 10.1002/iid3.875.

Longitudinal Analysis of Antiphospholipid Antibody Dynamics after Infection with SARS-CoV-2 or Vaccination with BNT162b2.

Ogric M, Zigon P, Sodin-Semrl S, Zlatkovic-Svenda M, Zdravkovic M, Ovuka M Int J Mol Sci. 2023; 24(1).

PMID: 36613655 PMC: 9820546. DOI: 10.3390/ijms24010211.